Craigavon, N.I. – Almac Sciences, a member of the Almac Group, has expanded its technology capabilities within its Active Pharmaceutical Ingredients (API) services & chemical development portfolio with the implementation of continuous flow expertise at its global headquarters in Craigavon, UK, with further plans to introduce flow capacity within Arran Chemical Company (Athlone, Ireland).
Continuous flow manufacture is an innovative technology platform which is gaining momentum within the pharmaceutical industry with the FDA supporting the adoption for the manufacture of APIs. It offers significant improvements in relation to product quality, process safety, reduction in plant footprint and provides the ability to perform chemistry that is difficult or impossible to do in batch mode.
Almac Sciences has a 4-year strategy to develop Flow Assisted Synthesis Technology (FAST) focusing on four key areas; (1) high pressure hydrogenations, (2) high energy chemistry, (3) oxidation and (4) photo-redox LED mediated chemistries. To support this, Almac Sciences has been awarded a Knowledge Transfer Partnership from Innovate UK for the development of novel routes to chiral amines using flow technology. In addition, Arran Chemical Company, in partnership with Queen’s University, Belfast, has been successful in securing a Horizon 2020 funded programme to support 4 PhD studentships for the next 4 years (beginning in 2019) in line with the FAST strategy.
Almac will develop highly flexible, robust, efficient flow technology platforms for continuous manufacture for the benefit of its clients who seek high quality and best-in-class pharmaceutical synthesis.
Prof. Tom Moody, VP Technology Development & Commercialisation, Almac & Arran Chemical Company commented, “The introduction of continuous flow technology further enhances Almac Sciences’ capabilities within API development and manufacture. Flow technology is highly flexible, robust, economic and regarded as the most exciting and innovative growth technology for the preparation of APIs. We are delighted to now offer this within our portfolio and will strive to continue providing world-class solutions to advance human health globally.”
Versalis to acquire remaining 60% stake in Finproject to become the Italian leader in the production of special polymers
Closing is expected in the fourth quarter of 2021 and follows Versalis’ acquisition of 40% of the company which took place in July 2020. The operation will allow for the development of more special...
Versalis to acquire technologies and plants for the new mechanical recycling hub at Porto Marghera, Italy
Versalis accelerates developments in advanced mechanical recycling and expand the portfolio of the Versalis Revive® range of recycled polymers, consolidating its European leadership in recycled sty...
Shell to build one of Europe’s biggest biofuels facilities in Rotterdam, The Netherlands
Shell announced to build an 820,000-tonnes-a-year biofuels facility that will be among the biggest in Europe to produce sustainable aviation fuel (SAF) and renewable diesel made from waste.
Cooperation Uniper and Port of Rotterdam Authority in production green hydrogen
The companies have entered into an agreement for developing the production of green hydrogen at the Uniper location on Maasvlakte.